Pericytes, an overlooked player in vascular pathobiology

Pharmacology and Therapeutics

Volumn 171, Issue , 2017, Pages 30-42

  Ferland McCollough, David ^a   Slater, Sadie ^a   Richard, Jai ^a   Reni, Carlotta ^a   Mangialardi, Giuseppe ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cancer stem cells; Diabetic nephropathy; Diabetic retinopathy; Pericyte fibrosis; Pericytes; Perivascular stem cells

Indexed keywords

BLOOD BRAIN BARRIER; CELL DENSITY; CELL THERAPY; CENTRAL NERVOUS SYSTEM; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DRUG DELIVERY SYSTEM; DRUG TARGETING; ERECTILE DYSFUNCTION; HUMAN; IMMUNOMODULATION; MALIGNANT NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PERICYTE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; TUMOR GROWTH; VASCULAR DISEASE; ANIMAL; CYTOLOGY; ISCHEMIA; MOLECULARLY TARGETED THERAPY; NEOPLASMS; VASCULAR DISEASES;

ANIMALS; DIABETES MELLITUS; HUMANS; ISCHEMIA; MOLECULAR TARGETED THERAPY; NEOPLASMS; PERICYTES; VASCULAR DISEASES;

EID: 85007550924     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2016.11.008     Document Type: Review

References (184)

1. Adapala, R.K., Thoppil, R.J., Ghosh, K., Cappelli, H.C., Dudley, A.C., Paruchuri, S.,.. Thodeti, C.K., Activation of mechanosensitive ion channel TRPV4 normalizes tumour vasculature and improves cancer therapy. Oncogene 35 (2016), 314–322.
2. Agrawal, V., Maharjan, S., Kim, K., Kim, N.J., Son, J., Lee, K.,.. Kwon, Y.G., Direct endothelial junction restoration results in significant tumour vascular normalization and metastasis inhibition in mice. Oncotarget 5 (2014), 2761–2777.
3. Armulik, A., Abramsson, A., Betsholtz, C., Endothelial/pericyte interactions. Circulation Research 97 (2005), 512–523.
4. Armulik, A., Genove, G., Mae, M., Nisancioglu, M.H., Wallgard, E., Niaudet, C.,.. Betsholtz, C., Pericytes regulate the blood-brain barrier. Nature 468 (2010), 557–561.
5. Askarinam, A., James, A.W., Zara, J.N., Goyal, R., Corselli, M., Pan, A.,.. Soo, C., Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with Nel-like molecule I protein. Tissue Engineering. Part A 19 (2013), 1386–1397.
6. Assero, G., Lupo, G., Anfuso, C.D., Ragusa, N., Alberghina, M., High glucose and advanced glycation end products induce phospholipid hydrolysis and phospholipid enzyme inhibition in bovine retinal pericytes. Biochimica et Biophysica Acta 1533 (2001), 128–140.
7. Avolio, E., Rodriguez-Arabaolaza, I., Spencer, H.L., Riu, F., Mangialardi, G., Slater, S.C.,.. Madeddu, P., Expansion and characterization of neonatal cardiac pericytes provides a novel cellular option for tissue engineering in congenital heart disease. Journal of the American Heart Association, 4, 2015, e002043.
8. Baelde, H.J., Eikmans, M., Lappin, D.W., Doran, P.P., Hohenadel, D., Brinkkoetter, P.T.,.. Bruijn, J.A., Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney International 71 (2007), 637–645.
9. Baluk, P., Morikawa, S., Haskell, A., Mancuso, M., McDonald, D.M., Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumours. The American Journal of Pathology 163 (2003), 1801–1815.
10. Banks, W.A., From blood-brain barrier to blood-brain interface: New opportunities for CNS drug delivery. Nature Reviews. Drug Discovery 15 (2016), 275–292.
11. Bara, J.J., Richards, R.G., Alini, M., Stoddart, M.J., Concise review: Bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: Implications for basic research and the clinic. Stem Cells 32 (2014), 1713–1723.
12. Batbold, D., Song, K.M., Park, J.M., Park, S.H., Lee, T., Ryu, D.S.,.. Suh, J.K., Sac-1004, a pseudo-sugar derivative of cholesterol, restores erectile function through reconstruction of nonleaky and functional cavernous angiogenesis in the streptozotocin induced diabetic mouse. The Journal of Urology 195 (2016), 1936–1946.
13. Bergers, G., Song, S., The role of pericytes in blood-vessel formation and maintenance. Neuro-Oncology 7 (2005), 452–464.
14. Birbrair, A., Zhang, T., Files, D.C., Mannava, S., Smith, T., Wang, Z.M.,.. Delbono, O., Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner. Stem Cell Research & Therapy, 5, 2014, 122.
15. Blocki, A., Wang, Y., Koch, M., Peh, P., Beyer, S., Law, P.,.. Raghunath, M., Not all MSCs can act as pericytes: Functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis. Stem Cells and Development 22 (2013), 2347–2355.
16. Boehm, B.O., Lang, G., Feldmann, B., Kurkhaus, A., Rosinger, S., Volpert, O.,.. Bouck, N., Proliferative diabetic retinopathy is associated with a low level of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor. A pilot study. Hormone and Metabolic Research 35 (2003), 382–386.
17. Boehm, B.O., Lang, G., Volpert, O., Jehle, P.M., Kurkhaus, A., Rosinger, S.,.. Bouck, N., Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy. Diabetologia 46 (2003), 394–400.
18. Bose, A., Barik, S., Banerjee, S., Ghosh, T., Mallick, A., Bhattacharyya Majumdar, S.,.. Majumdar, S., Tumour-derived vascular pericytes anergize Th cells. Journal of Immunology 191 (2013), 971–981.
19. Brand, C., Schliemann, C., Ring, J., Kessler, T., Baumer, S., Angenendt, L.,.. Schwoppe, C., NG2 proteoglycan as a pericyte target for anticancer therapy by tumour vessel infarction with retargeted tissue factor. Oncotarget 7 (2016), 6774–6789.
20. Brosius, F.C., Khoury, C.C., Buller, C.L., Chen, S., Abnormalities in signaling pathways in diabetic nephropathy. Expert Review of Endocrinology and Metabolism 5 (2010), 51–64.
21. Brunskill, E.W., Georgas, K., Rumballe, B., Little, M.H., Potter, S.S., Defining the molecular character of the developing and adult kidney podocyte. PloS One, 6, 2011, e24640.
22. Campagnolo, P., Cesselli, D., Al Haj Zen, A., Beltrami, A.P., Krankel, N., Katare, R.,.. Madeddu, P., Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation 121 (2010), 1735–1745.
23. Cao, Y., Zhang, Z.L., Zhou, M., Elson, P., Rini, B., Aydin, H.,.. Qian, C.N., Pericyte coverage of differentiated vessels inside tumour vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma. Cancer 119 (2013), 313–324.
24. Caplan, A.I., Adult mesenchymal stem cells: When, where, and how. Stem Cells International, 2015, 2015, 628767.
25. Cascone, T., Herynk, M.H., Xu, L., Du, Z., Kadara, H., Nilsson, M.B.,.. Heymach, J.V., Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma. The Journal of Clinical Investigation 121 (2011), 1313–1328.
26. Castela, A., Costa, C., Molecular mechanisms associated with diabetic endothelial-erectile dysfunction. Nature Reviews. Urology 13 (2016), 266–274.
27. Chang, F.C., Chou, Y.H., Chen, Y.T., Lin, S.L., Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis. Journal of the Formosan Medical Association 111 (2012), 589–598.
28. Chantrain, C.F., Henriet, P., Jodele, S., Emonard, H., Feron, O., Courtoy, P.J.,.. Marbaix, E., Mechanisms of pericyte recruitment in tumour angiogenesis: A new role for metalloproteinases. European Journal of Cancer 42 (2006), 310–318.
29. Chen, Y.T., Chang, F.C., Wu, C.F., Chou, Y.H., Hsu, H.L., Chiang, W.C.,.. Lin, S.L., Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney International 80 (2011), 1170–1181.
30. Chen, G., Chen, S.M., Wang, X., Ding, X.F., Ding, J., Meng, L.H., Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells. The Journal of Biological Chemistry 287 (2012), 12132–12141.
31. Chen, R.R., Silva, E.A., Yuen, W.W., Mooney, D.J., Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharmaceutical Research 24 (2007), 258–264.
32. Cheng, L., Huang, Z., Zhou, W., Wu, Q., Donnola, S., Liu, J.K.,.. Bao, S., Glioblastoma stem cells generate vascular pericytes to support vessel function and tumour growth. Cell 153 (2013), 139–152.
33. Chung, C.G., James, A.W., Asatrian, G., Chang, L., Nguyen, A., Le, K.,.. Soo, C., Human perivascular stem cell-based bone graft substitute induces rat spinal fusion. Stem Cells Translational Medicine, 4, 2015, 538.
34. Correa, D., Somoza, R.A., Lin, P., Schiemann, W.P., Caplan, A.I., Mesenchymal stem cells regulate melanoma cancer cells extravasation to bone and liver at their perivascular niche. International Journal of Cancer 138 (2016), 417–427.
35. Corselli, M., Chin, C.J., Parekh, C., Sahaghian, A., Wang, W., Ge, S.,.. Peault, B., Perivascular support of human hematopoietic stem/progenitor cells. Blood 121 (2013), 2891–2901.
36. Corselli, M., Crisan, M., Murray, I.R., West, C.C., Scholes, J., Codrea, F.,.. Peault, B., Identification of perivascular mesenchymal stromal/stem cells by flow cytometry. Cytometry. Part A 83 (2013), 714–720.
37. Corselli, M., Chen, C.W., Sun, B., Yap, S., Rubin, J.P., Peault, B., The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells and Development 21 (2012), 1299–1308.
38. Coughlan, M.T., Thorburn, D.R., Penfold, S.A., Laskowski, A., Harcourt, B.E., Sourris, K.C.,.. Forbes, J.M., RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. Journal of the American Society of Nephrology 20 (2009), 742–752.
39. Coward, R.J., Welsh, G.I., Yang, J., Tasman, C., Lennon, R., Koziell, A.,.. Saleem, M.A., The human glomerular podocyte is a novel target for insulin action. Diabetes 54 (2005), 3095–3102.
40. Crawford, C., Kennedy-Lydon, T., Sprott, C., Desai, T., Sawbridge, L., Munday, J.,.. Peppiatt-Wildman, C.M., An intact kidney slice model to investigate vasa recta properties and function in situ. Nephron. Physiology 120 (2012), 17–31.
41. Crisan, M., Corselli, M., Chen, W.C., Peault, B., Perivascular cells for regenerative medicine. Journal of Cellular and Molecular Medicine 16 (2012), 2851–2860.
42. Crisan, M., Yap, S., Casteilla, L., Chen, C.W., Corselli, M., Park, T.S.,.. Peault, B., A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3 (2008), 301–313.
43. Daneman, R., Zhou, L., Kebede, A.A., Barres, B.A., Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468 (2010), 562–566.
44. Dellavalle, A., Maroli, G., Covarello, D., Azzoni, E., Innocenzi, A., Perani, L.,.. Cossu, G., Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. Nature Communications, 2, 2011, 499.
45. Dessapt, C., Baradez, M.O., Hayward, A., Dei Cas, A., Thomas, S.M., Viberti, G., Gnudi, L., Mechanical forces and TGFbeta1 reduce podocyte adhesion through alpha3beta1 integrin downregulation. Nephrology, Dialysis, Transplantation 24 (2009), 2645–2655.
46. Diaz-Flores, L., Gutierrez, R., Madrid, J.F., Varela, H., Valladares, F., Acosta, E.,.. Diaz-Flores, L. Jr., Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histology and Histopathology 24 (2009), 909–969.
47. Dohgu, S., Takata, F., Yamauchi, A., Nakagawa, S., Egawa, T., Naito, M.,.. Kataoka, Y., Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production. Brain Research 1038 (2005), 208–215.
48. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D.,.. Horwitz, E., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8 (2006), 315–317.
49. Eid, A.A., Gorin, Y., Fagg, B.M., Maalouf, R., Barnes, J.L., Block, K., Abboud, H.E., Mechanisms of podocyte injury in diabetes: Role of cytochrome P450 and NADPH oxidases. Diabetes 58 (2009), 1201–1211.
50. Elman, M.J., Ayala, A., Bressler, N.M., Browning, D., Flaxel, C.J., Glassman, A.R.,.. Diabetic Retinopathy Clinical Research, N., Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-Year randomized trial results. Ophthalmology 122 (2015), 375–381.
51. Enge, M., Bjarnegard, M., Gerhardt, H., Gustafsson, E., Kalen, M., Asker, N.,.. Betsholtz, C., Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. The EMBO Journal 21 (2002), 4307–4316.
52. Eremina, V., Sood, M., Haigh, J., Nagy, A., Lajoie, G., Ferrara, N.,.. Quaggin, S.E., Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. The Journal of Clinical Investigation 111 (2003), 707–716.
53. Ezquer, F., Ezquer, M., Simon, V., Pardo, F., Yanez, A., Carpio, D., Conget, P., Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice. Biology of Blood and Marrow Transplantation 15 (2009), 1354–1365.
54. Fan, X., Khaki, L., Zhu, T.S., Soules, M.E., Talsma, C.E., Gul, N.,.. Eberhart, C.G., NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumour neurospheres and xenografts. Stem Cells 28 (2010), 5–16.
55. Fiorentino, L., Cavalera, M., Mavilio, M., Conserva, F., Menghini, R., Gesualdo, L., Federici, M., Regulation of TIMP3 in diabetic nephropathy: A role for microRNAs. Acta Diabetologica 50 (2013), 965–969.
56. Folkman, J., Role of angiogenesis in tumour growth and metastasis. Seminars in Oncology 29 (2002), 15–18.
57. Fong, D.S., Aiello, L., Gardner, T.W., King, G.L., Blankenship, G., Cavallerano, J.D.,.. American Diabetes, A., Retinopathy in diabetes. Diabetes Care 27:Suppl. 1 (2004), S84–S87.
58. Franco, M., Roswall, P., Cortez, E., Hanahan, D., Pietras, K., Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression. Blood 118 (2011), 2906–2917.
59. Furuhashi, M., Sjoblom, T., Abramsson, A., Ellingsen, J., Micke, P., Li, H.,.. Ostman, A., Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumours and an associated increase in tumour growth rate. Cancer Research 64 (2004), 2725–2733.
60. Gale, N.W., Thurston, G., Hackett, S.F., Renard, R., Wang, Q., McClain, J.,.. Yancopoulos, G.D., Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Developmental Cell 3 (2002), 411–423.
61. Glentis, A., Gurchenkov, V., Matic Vignjevic, D., Assembly, heterogeneity, and breaching of the basement membranes. Cell Adhesion & Migration 8 (2014), 236–245.
62. Guan, Y.Y., Luan, X., Xu, J.R., Liu, Y.R., Lu, Q., Wang, C.,.. Fang, C., Selective eradication of tumour vascular pericytes by peptide-conjugated nanoparticles for antiangiogenic therapy of melanoma lung metastasis. Biomaterials 35 (2014), 3060–3070.
63. Gubernator, M., Slater, S.C., Spencer, H.L., Spiteri, I., Sottoriva, A., Riu, F.,.. Madeddu, P., Epigenetic profile of human adventitial progenitor cells correlates with therapeutic outcomes in a mouse model of limb ischemia. Arteriosclerosis, Thrombosis, and Vascular Biology 35 (2015), 675–688.
64. Gupta, P.B., Chaffer, C.L., Weinberg, R.A., Cancer stem cells: Mirage or reality?. Nature Medicine 15 (2009), 1010–1012.
65. Hall, C.N., Reynell, C., Gesslein, B., Hamilton, N.B., Mishra, A., Sutherland, B.A.,.. Attwell, D., Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508 (2014), 55–60.
66. Haribalaganesh, R., Sheikpranbabu, S., Elayappan, B., Venkataraman, D., Gurunathan, S., Pigment-epithelium-derived factor down regulates hyperglycemia-induced apoptosis via PI3K/Akt activation in goat retinal pericytes. Angiogenesis 12 (2009), 381–389.
67. Hatini, V., Huh, S.O., Herzlinger, D., Soares, V.C., Lai, E., Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of Winged Helix transcription factor BF-2. Genes & Development 10 (1996), 1467–1478.
68. He, Y., Leung, K.W., Ren, Y., Pei, J., Ge, J., Tombran-Tink, J., PEDF improves mitochondrial function in RPE cells during oxidative stress. Investigative Ophthalmology & Visual Science 55 (2014), 6742–6755.
69. He, Y., Yao, Y., Tsirka, S.E., Cao, Y., Cell-culture models of the blood-brain barrier. Stroke 45 (2014), 2514–2526.
70. Heldin, C.H., Targeting the PDGF signaling pathway in tumour treatment. Cell Communication and Signaling: CCS, 11, 2013, 97.
71. Hellstrom, M., Gerhardt, H., Kalen, M., Li, X., Eriksson, U., Wolburg, H., Betsholtz, C., Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. The Journal of Cell Biology 153 (2001), 543–553.
72. Hill, R.A., Tong, L., Yuan, P., Murikinati, S., Gupta, S., Grutzendler, J., Regional blood flow in the normal and ischemic brain is controlled by arteriolar smooth muscle cell contractility and not by capillary pericytes. Neuron 87 (2015), 95–110.
73. Hong, J., Tobin, N.P., Rundqvist, H., Li, T., Lavergne, M., Garcia-Ibanez, Y.,.. Genove, G., Role of tumour pericytes in the recruitment of myeloid-derived suppressor cells. Journal of the National Cancer Institute, 2015, 107.
74. Huang, X., Molema, G., King, S., Watkins, L., Edgington, T.S., Thorpe, P.E., Tumour infarction in mice by antibody-directed targeting of tissue factor to tumour vasculature. Science 275 (1997), 547–550.
75. Humphreys, B.D., Lin, S.L., Kobayashi, A., Hudson, T.E., Nowlin, B.T., Bonventre, J.V.,.. Duffield, J.S., Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. The American Journal of Pathology 176 (2010), 85–97.
76. Iglesias-de la Cruz, M.C., Ziyadeh, F.N., Isono, M., Kouahou, M., Han, D.C., Kalluri, R.,.. Chen, S., Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney International 62 (2002), 901–913.
77. Ikebe, C., Suzuki, K., Mesenchymal stem cells for regenerative therapy: Optimization of cell preparation protocols. BioMed Research International, 2014, 2014, 951512.
78. Ito, S., Miyashita, H., Suzuki, Y., Kobayashi, M., Satomi, S., Sato, Y., Enhanced cancer metastasis in mice deficient in vasohibin-1 gene. PloS One, 8, 2013, e73931.
79. James, A.W., Zara, J.N., Corselli, M., Chiang, M., Yuan, W., Nguyen, V.,.. Soo, C., Use of human perivascular stem cells for bone regeneration. Journal of Visualized Experiments, 2012, e2952.
80. Jansson, D., Rustenhoven, J., Feng, S., Hurley, D., Oldfield, R.L., Bergin, P.S.,.. Dragunow, M., A role for human brain pericytes in neuroinflammation. Journal of Neuroinflammation, 11, 2014, 104.
81. Jayasinghe, C., Simiantonaki, N., Kirkpatrick, C.J., Histopathological features predict metastatic potential in locally advanced colon carcinomas. BMC Cancer, 15, 2015, 14.
82. Jimenez-Osorio, A.S., Gonzalez-Reyes, S., Pedraza-Chaverri, J., Natural Nrf2 activators in diabetes. Clinica Chimica Acta 448 (2015), 182–192.
83. Jin, J., Sison, K., Li, C., Tian, R., Wnuk, M., Sung, H.K.,.. Quaggin, S.E., Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell 151 (2012), 384–399.
84. Jo, V.Y., Fletcher, C.D., WHO classification of soft tissue tumours: An update based on the 2013 (4th) edition. Pathology 46 (2014), 95–104.
85. Katare, R., Riu, F., Mitchell, K., Gubernator, M., Campagnolo, P., Cui, Y.,.. Madeddu, P., Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circulation Research 109 (2011), 894–906.
86. Khan, S.S., Quaggin, S.E., Therapies on the horizon for diabetic kidney disease. Current Diabetes Reports, 15, 2015, 111.
87. Kida, Y., Duffield, J.S., Pivotal role of pericytes in kidney fibrosis. Clinical and Experimental Pharmacology & Physiology 38 (2011), 467–473.
88. Kidney Research UK. (2015).
89. Kitano, M., Bloomston, P.M., Hepatic stellate cells and microRNAs in pathogenesis of liver fibrosis. Journal of Clinical Medicine, 5, 2016.
90. Kramann, R., Goettsch, C., Wongboonsin, J., Iwata, H., Schneider, R.K., Kuppe, C.,.. Humphreys, B.D., Adventitial MSC-like cells are progenitors of vascular smooth muscle cells and drive vascular calcification in chronic kidney disease. Cell Stem Cell, 2016.
91. Kramann, R., Schneider, R.K., DiRocco, D.P., Machado, F., Fleig, S., Bondzie, P.A.,.. Humphreys, B.D., Perivascular Gli1 + progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 16 (2015), 51–66.
92. Krishna Priya, S., Nagare, R.P., Sneha, V.S., Sidhanth, C., Bindhya, S., Manasa, P., Ganesan, T.S., Tumour angiogenesis - Origin of blood vessels. International Journal of Cancer, 2016.
93. Kuninty, P.R., Schnittert, J., Storm, G., Prakash, J., MicroRNA targeting to modulate tumour microenvironment. Frontiers in Oncology, 6, 2016, 3.
94. Lander, H.M., Tauras, J.M., Ogiste, J.S., Hori, O., Moss, R.A., Schmidt, A.M., Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. The Journal of Biological Chemistry 272 (1997), 17810–17814.
95. Lassila, M., Jandeleit-Dahm, K., Seah, K.K., Smith, C.M., Calkin, A.C., Allen, T.J., Cooper, M.E., Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice. Journal of the American Society of Nephrology 16 (2005), 363–373.
96. LeBleu, V.S., Taduri, G., O'Connell, J., Teng, Y., Cooke, V.G., Woda, C.,.. Kalluri, R., Origin and function of myofibroblasts in kidney fibrosis. Nature Medicine 19 (2013), 1047–1053.
97. Lee, R.H., Seo, M.J., Reger, R.L., Spees, J.L., Pulin, A.A., Olson, S.D., Prockop, D.J., Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proceedings of the National Academy of Sciences of the United States of America 103 (2006), 17438–17443.
98. Li, J.J., Kwak, S.J., Jung, D.S., Kim, J.J., Yoo, T.H., Ryu, D.R.,.. Kang, S.W., Podocyte biology in diabetic nephropathy. Kidney International. Supplement, 2007, S36–S42.
99. Lin, S.L., Chang, F.C., Schrimpf, C., Chen, Y.T., Wu, C.F., Wu, V.C.,.. Duffield, J.S., Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. The American Journal of Pathology 178 (2011), 911–923.
100. Lin, S.L., Kisseleva, T., Brenner, D.A., Duffield, J.S., Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. The American Journal of Pathology 173 (2008), 1617–1627.
101. Liu, L., Hu, X., Cai, G.Y., Lv, Y., Zhuo, L., Gao, J.J.,.. Chen, X.M., High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling. Nephrology, Dialysis, Transplantation 27 (2012), 90–100.
102. Liu, Y., Leo, L.F., McGregor, C., Grivitishvili, A., Barnstable, C.J., Tombran-Tink, J., Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice. Molecular Medicine 18 (2012), 1387–1401.
103. Liu, B.C., Song, X., Lu, X.Y., Li, D.T., Eaton, D.C., Shen, B.Z.,.. Ma, H.P., High glucose induces podocyte apoptosis by stimulating TRPC6 via elevation of reactive oxygen species. Biochimica et Biophysica Acta 1833 (2013), 1434–1442.
104. Lv, Z., Hu, M., Ren, X., Fan, M., Zhen, J., Chen, L.,.. Wang, R., Fyn mediates high glucose-induced actin cytoskeleton reorganization of podocytes via promoting ROCK activation in vitro. Journal of Diabetes Research, 2016, 2016, 5671803.
105. Ma, T., Wang, Y., Qi, F., Zhu, S., Huang, L., Liu, Z.,.. Luo, Z., The effect of synthetic oxygen carrier-enriched fibrin hydrogel on Schwann cells under hypoxia condition in vitro. Biomaterials 34 (2013), 10016–10027.
106. Maeda, S., Matsui, T., Ojima, A., Takeuchi, M., Yamagishi, S., Sulforaphane inhibits advanced glycation end product-induced pericyte damage by reducing expression of receptor for advanced glycation end products. Nutrition Research 34 (2014), 807–813.
107. Mancuso, M.R., Davis, R., Norberg, S.M., O'Brien, S., Sennino, B., Nakahara, T.,.. McDonald, D.M., Rapid vascular regrowth in tumours after reversal of VEGF inhibition. The Journal of Clinical Investigation 116 (2006), 2610–2621.
108. Manda, G., Checherita, A.I., Comanescu, M.V., Hinescu, M.E., Redox signaling in diabetic nephropathy: Hypertrophy versus death choices in mesangial cells and podocytes. Mediators of Inflammation, 2015, 2015, 604208.
109. Mao, X.G., Xue, X.Y., Wang, L., Zhang, X., Yan, M., Tu, Y.Y.,.. Song, S.J., CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia. Neuro-Oncology 15 (2013), 865–879.
110. Martinez Jabaloyas, J.M., Gil Salom, M., Pastor Hernandez, F., Villamon Fort, R., Garcia Sisamon, F., Efficacy and safety of sildenafil in patients with erectile dysfunction and hypertension. Prognostic factors. Medicina Clínica (Barcelona) 119 (2002), 281–285.
111. McKendry, J.B., Collins, W.E., Silverman, M., Krul, L.E., Collins, J.P., Irvine, A.H., Erectile impotence: A clinical challenge. Canadian Medical Association Journal 128 (1983), 653–663.
112. McVicar, C.M., Ward, M., Colhoun, L.M., Guduric-Fuchs, J., Bierhaus, A., Fleming, T.,.. Stitt, A.W., Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice. Diabetologia 58 (2015), 1129–1137.
113. Miljkovic-Licina, M., Hammel, P., Garrido-Urbani, S., Lee, B.P., Meguenani, M., Chaabane, C.,.. Imhof, B.A., Targeting olfactomedin-like 3 inhibits tumour growth by impairing angiogenesis and pericyte coverage. Molecular Cancer Therapeutics 11 (2012), 2588–2599.
114. Mravic, M., LaChaud, G., Nguyen, A., Scott, M.A., Dry, S.M., James, A.W., Clinical and histopathological diagnosis of glomus tumour: An institutional experience of 138 cases. International Journal of Surgical Pathology 23 (2015), 181–188.
115. Mustapha, N.M., Tarr, J.M., Kohner, E.M., Chibber, R., NADPH oxidase versus mitochondria-derived ROS in glucose-induced apoptosis of pericytes in early diabetic retinopathy. Journal of Ophthalmology, 2010, 2010, 746978.
116. Navis, A.C., Hamans, B.C., Claes, A., Heerschap, A., Jeuken, J.W., Wesseling, P., Leenders, W.P., Effects of targeting the VEGF and PDGF pathways in diffuse orthotopic glioma models. The Journal of Pathology 223 (2011), 626–634.
117. Nishikawa, T., Edelstein, D., Du, X.L., Yamagishi, S., Matsumura, T., Kaneda, Y.,.. Brownlee, M., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000), 787–790.
118. Nishimura, A., Ago, T., Kuroda, J., Arimura, K., Tachibana, M., Nakamura, K.,.. Kitazono, T., Detrimental role of pericyte Nox4 in the acute phase of brain ischemia. Journal of Cerebral Blood Flow and Metabolism, 2015.
119. Nolan-Stevaux, O., Truitt, M.C., Pahler, J.C., Olson, P., Guinto, C., Lee, D.C., Hanahan, D., Differential contribution to neuroendocrine tumourigenesis of parallel egfr signaling in cancer cells and pericytes. Genes & Cancer 1 (2010), 125–141.
120. Ochs, K., Sahm, F., Opitz, C.A., Lanz, T.V., Oezen, I., Couraud, P.O.,.. Platten, M., Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma. Journal of Neuroimmunology 265 (2013), 106–116.
121. O'Donovan, H.C., Hickey, F., Brazil, D.P., Kavanagh, D.H., Oliver, N., Martin, F.,.. Crean, J., Connective tissue growth factor antagonizes transforming growth factor-beta1/Smad signalling in renal mesangial cells. Biochemical Journal 441 (2012), 499–510.
122. O'Keeffe, M.B., Devlin, A.H., Burns, A.J., Gardiner, T.A., Logan, I.D., Hirst, D.G., McKeown, S.R., Investigation of pericytes, hypoxia, and vascularity in bladder tumours: Association with clinical outcomes. Oncology Research 17 (2008), 93–101.
123. Omidi, Y., Barar, J., Impacts of blood-brain barrier in drug delivery and targeting of brain tumours. BioImpacts: BI 2 (2012), 5–22.
124. Onoyama, M., Kitadai, Y., Tanaka, Y., Yuge, R., Shinagawa, K., Tanaka, S.,.. Chayama, K., Combining molecular targeted drugs to inhibit both cancer cells and activated stromal cells in gastric cancer. Neoplasia 15 (2013), 1391–1399.
125. Pallone, T.L., Silldorff, E.P., Pericyte regulation of renal medullary blood flow. Experimental Nephrology 9 (2001), 165–170.
126. Paquet-Fifield, S., Schluter, H., Li, A., Aitken, T., Gangatirkar, P., Blashki, D.,.. Kaur, P., A role for pericytes as microenvironmental regulators of human skin tissue regeneration. The Journal of Clinical Investigation 119 (2009), 2795–2806.
127. Pardridge, W.M., Blood-brain barrier delivery. Drug Discovery Today 12 (2007), 54–61.
128. Park, T.S., Gavina, M., Chen, C.W., Sun, B., Teng, P.N., Huard, J.,.. Peault, B., Placental perivascular cells for human muscle regeneration. Stem Cells and Development 20 (2011), 451–463.
129. Park, S.W., Yun, J.H., Kim, J.H., Kim, K.W., Cho, C.H., Kim, J.H., Angiopoietin 2 induces pericyte apoptosis via alpha3beta1 integrin signaling in diabetic retinopathy. Diabetes 63 (2014), 3057–3068.
130. Paul, G., Ozen, I., Christophersen, N.S., Reinbothe, T., Bengzon, J., Visse, E.,.. Brundin, P., The adult human brain harbors multipotent perivascular mesenchymal stem cells. PloS One, 7, 2012, e35577.
131. Pedrosa, A.R., Trindade, A., Carvalho, C., Graca, J., Carvalho, S., Peleteiro, M.C.,.. Duarte, A., Endothelial Jagged1 promotes solid tumour growth through both pro-angiogenic and angiocrine functions. Oncotarget 6 (2015), 24404–24423.
132. Pieper, C., Pieloch, P., Galla, H.J., Pericytes support neutrophil transmigration via interleukin-8 across a porcine co-culture model of the blood-brain barrier. Brain Research 1524 (2013), 1–11.
133. Pop-Busui, R., Sima, A., Stevens, M., Diabetic neuropathy and oxidative stress. Diabetes/Metabolism Research and Reviews 22 (2006), 257–273.
134. Proebstl, D., Voisin, M.B., Woodfin, A., Whiteford, J., D'Acquisto, F., Jones, G.E.,.. Nourshargh, S., Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. The Journal of Experimental Medicine 209 (2012), 1219–1234.
135. Punsoni, M., Drexler, S., Palaia, T., Stevenson, M., Stecker, M.M., Acute anoxic changes in peripheral nerve: Anatomic and physiologic correlations. Brain and Behavior: A Cognitive Neuroscience Perspective, 5, 2015, e00347.
136. Ricci-Vitiani, L., Pallini, R., Biffoni, M., Todaro, M., Invernici, G., Cenci, T.,.. De Maria, R., Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468 (2010), 824–828.
137. Robison, W.G. Jr., Kador, P.F., Kinoshita, J.H., Early retinal microangiopathy: Prevention with aldose reductase inhibitors. Diabetic Medicine 2 (1985), 196–199.
138. Ruan, J., Luo, M., Wang, C., Fan, L., Yang, S.N., Cardenas, M.,.. Hajjar, K.A., Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes. Blood 121 (2013), 5192–5202.
139. Rybinski, K., Imtiyaz, H.Z., Mittica, B., Drozdowski, B., Fulmer, J., Furuuchi, K.,.. Zhou, Y., Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumour microvasculature. Oncotarget 6 (2015), 25429–25440.
140. Saleem, M.A., O'Hare, M.J., Reiser, J., Coward, R.J., Inward, C.D., Farren, T.,.. Mundel, P., A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. Journal of the American Society of Nephrology 13 (2002), 630–638.
141. Satchell, S.C., Harper, S.J., Tooke, J.E., Kerjaschki, D., Saleem, M.A., Mathieson, P.W., Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. Journal of the American Society of Nephrology 13 (2002), 544–550.
142. Schlondorff, D., The glomerular mesangial cell: An expanding role for a specialized pericyte. The FASEB Journal 1 (1987), 272–281.
143. Schmidt, M., Giessl, A., Laufs, T., Hankeln, T., Wolfrum, U., Burmester, T., How does the eye breathe? Evidence for neuroglobin-mediated oxygen supply in the mammalian retina. The Journal of Biological Chemistry 278 (2003), 1932–1935.
144. Scholz, A., Harter, P.N., Cremer, S., Yalcin, B.H., Gurnik, S., Yamaji, M.,.. Reiss, Y., Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Molecular Medicine 8 (2016), 39–57.
145. Schweizer, L., Koelsche, C., Sahm, F., Piro, R.M., Capper, D., Reuss, D.E.,.. von Deimling, A., Meningeal hemangiopericytoma and solitary fibrous tumours carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathologica 125 (2013), 651–658.
146. Scully, S., Francescone, R., Faibish, M., Bentley, B., Taylor, S.L., Oh, D.,.. Shao, R., Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas. The Journal of Neuroscience 32 (2012), 12950–12960.
147. Shankland, S.J., Al'Douahji, M., Cell cycle regulatory proteins in glomerular disease. Experimental Nephrology 7 (1999), 207–211.
148. Sheikpranbabu, S., Haribalaganesh, R., Gurunathan, S., Pigment epithelium-derived factor inhibits advanced glycation end-products-induced cytotoxicity in retinal pericytes. Diabetes & Metabolism 37 (2011), 505–511.
149. Shen, J., Shrestha, S., Yen, Y.H., Asatrian, G., Mravic, M., Soo, C.,.. James, A.W., Pericyte antigens in perivascular soft tissue tumours. International Journal of Surgical Pathology 23 (2015), 638–648.
150. Shepro, D., Morel, N.M., Pericyte physiology. The FASEB Journal 7 (1993), 1031–1038.
151. Siao, C.J., Lorentz, C.U., Kermani, P., Marinic, T., Carter, J., McGrath, K.,.. Hempstead, B.L., ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activation. The Journal of Experimental Medicine 209 (2012), 2291–2305.
152. Singh, R., Barden, A., Mori, T., Beilin, L., Advanced glycation end-products: A review. Diabetologia 44 (2001), 129–146.
153. Siqueira, R.C., Messias, A., Messias, K., Arcieri, R.S., Ruiz, M.A., Souza, N.F.,.. Jorge, R., Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (Reticell-clinical trial). Stem Cell Research & Therapy, 6, 2015, 29.
154. Song, N., Huang, Y., Shi, H., Yuan, S., Ding, Y., Song, X.,.. Luo, Y., Overexpression of platelet-derived growth factor-BB increases tumour pericyte content via stromal-derived factor-1alpha/CXCR4 axis. Cancer Research 69 (2009), 6057–6064.
155. Stratman, A.N., Malotte, K.M., Mahan, R.D., Davis, M.J., Davis, G.E., Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 114 (2009), 5091–5101.
156. Susztak, K., Raff, A.C., Schiffer, M., Bottinger, E.P., Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55 (2006), 225–233.
157. Suzuki, S., Heldin, C.H., Heuchel, R.L., Platelet-derived growth factor receptor-beta, carrying the activating mutation D849N, accelerates the establishment of B16 melanoma. BMC Cancer, 7, 2007, 224.
158. Terada, T., Minute myopericytoma of the neck: A case report with literature review and differential diagnosis. Pathology Oncology Research 16 (2010), 613–616.
159. Terada, T., Myopericytoma of low grade malignancy in the oral cavity. Rare Tumours, 4, 2012, e9.
160. Thoppil, R.J., Cappelli, H.C., Adapala, R.K., Kanugula, A.K., Paruchuri, S., Thodeti, C.K., TRPV4 channels regulate tumour angiogenesis via modulation of Rho/Rho kinase pathway. Oncotarget, 2016.
161. Traktuev, D.O., Merfeld-Clauss, S., Li, J., Kolonin, M., Arap, W., Pasqualini, R.,.. March, K.L., A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circulation Research 102 (2008), 77–85.
162. Tu, Z., Li, Y., Smith, D.S., Sheibani, N., Huang, S., Kern, T., Lin, F., Retinal pericytes inhibit activated T cell proliferation. Investigative Ophthalmology & Visual Science 52 (2011), 9005–9010.
163. Ullah, I., Subbarao, R.B., Rho, G.J., Human mesenchymal stem cells - Current trends and future prospective. Bioscience Reports, 35, 2015.
164. Valdez, Y., Maia, M., Conway, E.M., CD248: Reviewing its role in health and disease. Current Drug Targets 13 (2012), 432–439.
165. Veron, D., Reidy, K.J., Bertuccio, C., Teichman, J., Villegas, G., Jimenez, J.,.. Tufro, A., Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. Kidney International 77 (2010), 989–999.
166. Vinik, A.I., Erbas, T., Diabetic autonomic neuropathy. Handbook of Clinical Neurology 117 (2013), 279–294.
167. von Tell, D., Armulik, A., Betsholtz, C., Pericytes and vascular stability. Experimental Cell Research 312 (2006), 623–629.
168. Wang, R., Chadalavada, K., Wilshire, J., Kowalik, U., Hovinga, K.E., Geber, A.,.. Tabar, V., Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468 (2010), 829–833.
169. Wells, J.A., Glassman, A.R., Ayala, A.R., Jampol, L.M., Bressler, N.M., Bressler, S.B.,.. Diabetic Retinopathy Clinical Research, N., Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: Two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology, 2016.
170. Welsh, G.I., Hale, L.J., Eremina, V., Jeansson, M., Maezawa, Y., Lennon, R.,.. Coward, R.J., Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metabolism 12 (2010), 329–340.
171. Welte, Y., Adjaye, J., Lehrach, H.R., Regenbrecht, C.R., Cancer stem cells in solid tumours: Elusive or illusive?. Cell Communication and Signaling: CCS, 8, 2010, 6.
172. Xian, X., Hakansson, J., Stahlberg, A., Lindblom, P., Betsholtz, C., Gerhardt, H., Semb, H., Pericytes limit tumour cell metastasis. The Journal of Clinical Investigation 116 (2006), 642–651.
173. Xu, Z., Wei, Y., Gong, J., Cho, H., Park, J.K., Sung, E.R.,.. Duh, E.J., NRF2 plays a protective role in diabetic retinopathy in mice. Diabetologia 57 (2014), 204–213.
174. Yamagishi, S., Inagaki, Y., Amano, S., Okamoto, T., Takeuchi, M., Makita, Z., Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties. Biochemical and Biophysical Research Communications 296 (2002), 877–882.
175. Yamagishi, S., Inagaki, Y., Okamoto, T., Amano, S., Koga, K., Takeuchi, M., Makita, Z., Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. The Journal of Biological Chemistry 277 (2002), 20309–20315.
176. Yasuda, H., Dyck, P.J., Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 37 (1987), 20–28.
177. Yin, G.N., Das, N.D., Choi, M.J., Song, K.M., Kwon, M.H., Ock, J.,.. Suh, J.K., The pericyte as a cellular regulator of penile erection and a novel therapeutic target for erectile dysfunction. Scientific Reports, 5, 2015, 10891.
178. Yonenaga, Y., Mori, A., Onodera, H., Yasuda, S., Oe, H., Fujimoto, A.,.. Imamura, M., Absence of smooth muscle actin-positive pericyte coverage of tumour vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients. Oncology 69 (2005), 159–166.
179. Yoshida, Y., Yamagishi, S., Matsui, T., Nakamura, K., Imaizumi, T., Yoshimura, K., Yamakawa, R., Positive correlation of pigment epithelium-derived factor and total antioxidant capacity in aqueous humour of patients with uveitis and proliferative diabetic retinopathy. The British Journal of Ophthalmology 91 (2007), 1133–1134.
180. Zang, G., Gustafsson, K., Jamalpour, M., Hong, J., Genove, G., Welsh, M., Vascular dysfunction and increased metastasis of B16F10 melanomas in Shb deficient mice as compared with their wild type counterparts. BMC Cancer, 15, 2015, 234.
181. Zhang, S.X., Wang, J.J., Dashti, A., Wilson, K., Zou, M.H., Szweda, L.,.. Lyons, T.J., Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein. Journal of Molecular Endocrinology 41 (2008), 135–143.
182. Zhang, S.X., Wang, J.J., Gao, G., Parke, K., Ma, J.X., Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy. Journal of Molecular Endocrinology 37 (2006), 1–12.
183. Zhong, Q., Mishra, M., Kowluru, R.A., Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy. Investigative Ophthalmology & Visual Science 54 (2013), 3941–3948.
184. Ziyadeh, F.N., Hoffman, B.B., Han, D.C., Iglesias-De La Cruz, M.C., Hong, S.W., Isono, M.,.. Sharma, K., Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proceedings of the National Academy of Sciences of the United States of America 97 (2000), 8015–8020.